Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Acute Myelogenous Leukemia (AML) Clinical Trials

A listing of Acute Myelogenous Leukemia (AML) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 Last 

California

Research Site
Duarte California 91010

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

University of California San Francisco Fresno Campus
Fresno California 93701
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

UCLA
Los Angeles California 90095-6956
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Sharp Memorial Hospital
San Diego California 92123
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Stanford Cancer Center
Stanford California 94305-582
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Research Site
Stanford California 94305

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Innovative Clinical Research Institute
Whittier California 90603
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Colorado

Rocky Mountain Cancer Center
Denver Colorado 80218-1210
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Connecticut

The Hospital of Central Connecticut
Southington Connecticut 6489
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Florida

University of Florida Health Cancer Center at Orlando Health
Orlando Florida 32806
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Georgia

Research Site
Atlanta Georgia 30322

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Memorial University Medical Center
Savannah Georgia 31404

AAML1031, A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443) and Sorafenib (IND# 69896) for Patients with High Allelic Ratio FLT3/ITD

View More »

Emory University Winship Cancer Institute
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Omacetaxine to evaluate Acute Myelogenous Leukemia (AML)

Illinois

Northwestern University Medical Center Division of Hematology/Oncology
Chicago Illinois 60611
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Research Site
Chicago Illinois 60637

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Cancer Care and Hematology Specialists of Chicagoland, P.C. - Niles, IL
Niles Illinois 60714
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Indiana

Indiana University Cancer Center
Indianapolis Indiana 46202-528
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Research Site
Indianapolis Indiana 46202

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Kansas

Kansas University Medical Center
Westwood Kansas 66205
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Louisiana

Ochsner Clinic Foundation
New Orleans Louisiana 70121-2483
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Massachusetts

Beth Israel Deaconess Medical Center
Boston Massachusetts 2215
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

University of Massachusetts
Worcester Massachusetts 1655
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Minnesota

Mayo Clinic
Rochester Minnesota 55905
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Research Site
Rochester Minnesota 55905

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Missouri

Kansas City VA Medical Center/University of Kansas Medical Center
Kansas City Missouri 64128
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Research Site
Springfield Missouri 65807

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Washington University School of Medicine
St. Louis Missouri 63110
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Nebraska

Research Site
Omaha Nebraska 68198

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

New Jersey

Research Site
Camden New Jersey 08103

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

John Theruer Cancer Center at Hackensack University Medical Center
Hackensack New Jersey 7601
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Cancer Institute of New Jersey
New Brunswick New Jersey 8901
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

New York

Winthrop University Hospital
Mineola New York 11501-3893
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Mt. Sinai Medical Center
New York New York 10029
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Weill Cornell Medical College
New York New York 10065
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Columbia University Medical Center
New York New York 10032
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

University of Rochester Medical Center
Rochester New York 14642
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

New York Medical College
Valhalla New York 10595
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

North Carolina

Duke University Medical Center
Durham North Carolina 27705
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Wake Forest University Health Sciences
Winston-Salem North Carolina 27157
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Ohio

University Hospitals Case Medical Center
Cleveland Ohio 44106
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Oregon

Research Site
Portland Oregon 97239

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Pennsylvania

UPMC Cancer Pavillion
Pittsburgh Pennsylvania 70121-2483
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

South Carolina

Research Site
Charleston South Carolina 29425

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Cancer Center of the Carolinas
Greenville South Carolina 29605
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Tennessee

Tennessee Oncology
Nashville Tennessee 37203
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Vanderbilt University Medical Center
Nashville Tennessee 37232-5505
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Texas

University of Texas Southwestern Medical Center
Dallas Texas 75390-9068
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Brooke-Army Medical Center
Fort Sam Houston Texas 78234
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

MD Anderson Cancer Center
Houston Texas 77030
New

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myloid leukemia in complete remission

Research Site
Houston Texas 77030

Safety and Efficacy Study of Pracinostat with Azacitadine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

First 1 2 3 4 Last